Plaintiffs seek to attach assets of compounding company linked to meningitis

In a two-hour hearing, lawyers battled over whether a federal judge should order the attachment of up to $461 million in assets belonging to New England Compounding Pharmacy Inc.—which is primarily linked to a fungal meningitis outbreak that caused 34 deaths—and other related companies and individuals. 

This article requires free registration

This article requires free registration to The National Law Journal. Please sign in or register to read the full text.